Australia Markets closed

Why Novita Healthcare wants more cash

Motley Fool Staff
medical app, medical, healthcare, mobile

On October 24 2019 the Novita Healthcare Ltd (ASX: NHL) share price climbed 145 per cent in a single trading day after it announced its TaliDetect technology had been approved for commercial use in the U.S.

According to the announcement TaliDetect is an electronic screening platform that helps screen for potential attention deficits in children. On the back of the news the stock closed up 145% at 2.7 cents and nearly quadrupled again to close at 10.7 cents on November 6, 2019. 

It has since fallen back to 6.9 cents.

For the quarter ending September 30 2019 it posted an operating cash loss of $757,000 on income of just $15,000.  

It also had cash on hand of just $1.45 million with estimated cash outflows of $767,000 over the December quarter. So we can see why it’s asked for a trading halt today as it prepares to ask existing shareholders to tip more money into the business. 

The post Why Novita Healthcare wants more cash appeared first on Motley Fool Australia.

Our Top 3 Blue Chip Shares for 2019 – NOW AVAILABLE!

You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.

So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!

Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...

While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...

Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.

You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!


More reading

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019